Low Molecular Weight Heparin as Thromboprophylaxis Throughout Pregnancy in Heritable Thrombophilic Women

Preston FE , Rosendaal FR , Walker ID , et al. Increased fetal loss in women with heritable thrombophilia. Lancet 1996;348:913.

Rai R. , Regan L. , Hadley E. , et al. Second-trimester pregnancy loss is associated with activated protein C resistance. Br J Haematol 1996;92:489.

Brenner B. , Blumenfeld Z. Thrombophilia and fetal loss. Blood Rev 1997 ;11:72.

Toglia MR , Weg JG Venous thromboembolism during pregnancy. N Engl J Med 1996;335:108.

Forestier F. , Sole Y. , Aiach M. , et al. Absence of transplacental passage of Fragmin (Kabi) during the second and third trimesters of pregnancy . Thromb Haemost 1992;67:180.

Harenberg J. , Schneider D. , Heilmann L. , Wolf H. Lack of anti-factor Xa activity in umbilical cord vein samples after subcutaneous administration of heparin or low molecular mass heparin in pregnant women. Haemostasis 1993;23:314.

Wahlberg TB , Kher A. Low molecular weight heparin as thromboprophylaxis in pregnancy. Haemostasis 1994;24:55.

Boda Z. , Laszlo P. , Rejtö L. , et al. Low molecular weight heparin as thromboprophylaxis in familial thrombophilia during the whole period of pregnancy. Thromb Haemost 1996;76:128.

Hunt BJ , Doughty HA , Majumdar G. , et al. Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies. Thromb Haemost 1997 ;77:39.

Blomback M. , Bremme K. , Hellgreen M. , et al. Thromboprophylaxis with low molecular mass heparin, Fragmin (dalteparin), during pregnancy—a longitudinal safety study. Blood Coagul Fibrinolysis 1998 ;9: 1.